Principelle
Principelle If Medical Grade Honey Bioactive Wound Care Dressing 8cm x 10cm Box of 10
Principelle If Medical Grade Honey Bioactive Wound Care Dressing 8cm x 10cm Box of 10
无法加载取货服务可用情况
Principelle If Medical Grade Honey Bioactive Wound Care Dressing (8 cm × 10 cm, Box of 10) delivers the same ≥18% w/w Leptospermum honey antimicrobial chemistry as the 8×20 cm format in a smaller footprint optimised for localised wound sites where the larger format would require cutting and may compromise dressing geometry.
Technical Specifications
| Parameter | Specification |
|---|---|
| Honey Concentration | ≥18% w/w standardised medical-grade Leptospermum honey |
| Dressing Dimensions | 8 cm × 10 cm |
| Pack Size | Box of 10 dressings |
| Dressing Type | Non-adhesive antimicrobial wound contact layer |
| Antimicrobial Spectrum | MRSA, MSSA, Pseudomonas aeruginosa, ESBL-producing Enterobacteriaceae |
| Mechanism | Glucose-oxidase H₂O₂ generation; osmotic bacteriostasis; low wound pH |
| Format Advantage | Optimised for heel wounds, digit wounds, small pressure injuries, STSG donor sites |
| Indications | DFU forefoot/toe, heel pressure injuries (Stage II–III), paediatric wounds, post-debridement wounds |
| Sterility | Sterile; single-use; gamma-irradiated |
| Biocompatibility | ISO 10993 tested; latex-free |
| Quality Management | ISO 13485:2016 |
| Singapore Registration | HSA-registered Class B medical device |
Clinical Q&A
Q: When is the 8×10 cm format preferred over the 8×20 cm format?
A: The 8×10 cm format is clinically preferred for: diabetic foot ulcers on the forefoot or toe regions where wound geometry is compact; Stage II–III heel pressure injuries where the wound area typically measures 6–9 cm²; paediatric wound sites; and post-debridement cavities where the smaller format fills the wound margin more precisely. The 8×20 cm format is better suited for venous leg ulcers in the gaiter zone (elongated anatomy) or large sacral pressure injuries.
Q: How does medical-grade Leptospermum honey achieve MRSA suppression without antibiotic resistance?
A: Leptospermum honey's antimicrobial activity operates through three simultaneous non-specific mechanisms: (1) H₂O₂ generation via glucose-oxidase — a reactive oxygen species mechanism to which bacteria cannot develop enzymatic resistance; (2) hyperosmotic stress causing bacterial cell dehydration; (3) low wound pH (3.2–4.5) inhibiting bacterial metalloprotease virulence factors. Unlike antibiotics, which target single bacterial proteins susceptible to mutation-based resistance, these physical and chemical stressors cannot be evaded by simple genetic mutation.
Q: Is the dressing appropriate for tunnelling or undermining wound cavities?
A: The Principelle If dressing is a flat wound contact layer and is not designed for packing deep tunnels. For tunnelling wounds, honey-impregnated rope/ribbon packing or gel formats are more appropriate. The 8×10 cm contact layer is best applied to surface wound beds and shallow cavities where it can maintain direct contact with the wound tissue surface.
Q: Can this dressing be used on wounds with concurrent systemic antibiotic therapy?
A: Yes. Principelle If operates independently of systemic antibiotic status. In polymicrobial or antibiotic-resistant wound infections, the honey contact layer provides local antimicrobial activity complementing systemic therapy — addressing surface biofilm that systemic agents cannot penetrate effectively. There are no known interactions between honey wound dressings and systemic antibiotics.
Q: What change frequency is recommended for DFU forefoot wounds?
A: For diabetic foot ulcers with moderate exudate, every 2–3 days with concurrent offloading is typically appropriate. Daily changes may be required in the presence of heavy exudate or clinical infection. Periwound skin maceration should be monitored at each change and managed with barrier film if present.
Regulatory & Standards References
- ISO 13485:2016 — Medical devices quality management; Principelle If manufacturing certification
- ISO 10993 — Biological evaluation of medical devices; biocompatibility confirmed for wound contact use
- HSA Singapore — Class B medical device registration under the Health Products Act
- IWGDF Guidelines 2023 — International Working Group on the Diabetic Foot; antimicrobial dressings recommended for infected DFU management
分享
